Stock listing
Frankfurt:C68 Crescent Biopharma, Inc. Aktie
German listing (Frankfurt) of Crescent Biopharma, Inc. · home listing NASDAQ:CBIO
Follow Crescent Biopharma, Inc. into a list and get an email when it puts out news.
Share price · FWB:C68
€11.90 EUR +1.20 (+11.2%)
Close on Oct 30, 2026
- Day range
- €11.90 – €11.90 EUROct 30, 2026
- Market cap
- €442.0M EURAt the close on Oct 30, 2026 · price × 37.15M shares outstanding
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:CBIO · Home | $13.48 USD | -0.59 (-4.2%) | 189,518 | $13.94 | $14.57 | $13.31 | $14.07 | Close on Oct 30, 2026 |
| Frankfurt:C68 | €11.90 EUR | +1.20 (+11.2%) | — | €11.90 | €11.90 | €11.90 | €10.70 | Close on Oct 30, 2026 |
- Ticker
- Frankfurt:C68
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- Frankfurt
- Currency
- EUR
What changed lately
Latest news release · Oct 15, 2026
Crescent Biopharma Announces Clinical Pipeline Momentum, including Enrolling Patients in Standard of Care Chemotherapy Combination Cohorts of Global Phase 1/2 ASCEND Trial of CR-001, a PD-1 x VEGF Bispecific Antibody, and Initiation of Additional ADC Combination Studies with CR-001
Latest deck · October 2026
Investor Presentation (October 2026)
Investor deck · 56 slides
Calls
Replays
GlycoMimetics, Inc. (GLYC) Q1 2024 Earnings Call
Thu, May 09, 2024 · 8:30 AM ET
Watch TranscriptGlycoMimetics, Inc. (GLYC) Q4 2023 Earnings Call
Wed, Mar 27, 2024 · 8:30 AM ET
Watch TranscriptGlycoMimetics, Inc. (GLYC) Q3 2023 Earnings Call
Fri, Nov 03, 2023 · 8:30 AM ET
Watch Transcript
Latest news
Financings
Public offering of ordinary shares and pre-funded warrants
Jul 30, 2026
Closed: US$143.7M in the latest tranche · US$14.5 a share · Jefferies +4
Dealers: Jefferies (co-lead), TD Cowen (co-lead), Guggenheim Securities (co-lead), Cantor (co-lead), LifeSci Capital
Announced Jul 14, 2026 · Update Jul 15, 2026 · Closed Jul 16, 2026 · Closed Jul 30, 2026
Decks
Investor Presentation (October 2026)
Investor deck · 56 slides · October 2026
Investor Presentation (December 2025)
Investor deck · 53 slides · Dec 4, 2025
Glycomimetics — Merger or Acquisition (April 2025)
Merger or acquisition · 27 slides · Apr 3, 2025
Glycomimetics — Merger or Acquisition (February 2025)
Merger or acquisition · 27 slides · Feb 28, 2025
Crescent Biopharma, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 22 in the last 12 months · 25 in all · newest Oct 15, 2026 · oldest 2025
- Calls
- 13 calls with a replay · 13 with a transcript · latest May 9, 2024
- Decks
- 6 decks · latest October 2026
Where Crescent Biopharma, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:CBIO · Home listing | NASDAQ | United States | USD |
| Lang & Schwarz:A41BDZ | Lang & Schwarz | Germany | EUR |
| BOATS:CBIO | BOATS | United States | USD |
| Frankfurt:C68 · This page | Frankfurt | Germany | EUR |
| gettex:C68 | gettex | Germany | EUR |
Log in to ask 6ix AI your own questions about Crescent Biopharma, Inc.